A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.

scientific article published on 24 February 2003

A multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/367898
P698PubMed publication ID12599045
P5875ResearchGate publication ID10889496

P50authorHoosen CoovadiaQ20656400
Dhayendre MoodleyQ42544603
Jagidesa MoodleyQ91877417
Glenda GrayQ17579989
P2093author name stringDavid Hall
James McIntyre
John L Sullivan
Patrick Robinson
Maria Gigliotti
Cheryl Nikodem
Justus Hofmyer
Lynette Boshoff
South African Intrapartum Nevirapine Trial (SAINT) Investigators
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectzidovudineQ198504
nevirapineQ263713
lamivudineQ422631
postpartum periodQ749115
randomized controlled trialQ1436668
multicenter clinical trialQ6934595
P304page(s)725-735
P577publication date2003-02-24
P1433published inJournal of Infectious DiseasesQ4051141
P1476titleA multicenter randomized controlled trial of nevirapine versus a combination of zidovudine and lamivudine to reduce intrapartum and early postpartum mother-to-child transmission of human immunodeficiency virus type 1.
P478volume187